Tuberculosis Cohort Avicenne Hospital
Tuberculosis (TB) is a serious infectious disease, second only to COVID-19 in deaths globally. In some parts of France, especially areas with diverse populations and economic challenges, TB cases are higher. This study, led by Avicenne Hospital, aims to understand why some people with TB don't get better from their treatment. Researchers will collect health information from patients newly diagnosed with TB to identify patterns and challenges. The goal is to discover ways to improve TB care and control the disease more effectively. This information will help develop better strategies to ensure more people successfully recover from TB, ultimately working towards reducing its impact worldwide.
At a glance
What is this study about?
Tuberculosis, often called TB, is a type of infection that mostly affects the lungs but can also affect other parts of the body. It’s a serious illness and unfortunately, it's still a major health problem around the world. In fact, after COVID-19, TB causes the most deaths from an infectious disease globally. Some areas, including parts of France, have higher rates of TB, particularly among people who have moved from other countries or live in areas with difficult social and economic conditions. This means it's really important to understand more about how TB affects different people.
This study, based at Avicenne Hospital, is trying to understand why some people with TB don't get better as expected, even when they’re receiving treatment. Currently, there isn't a comprehensive and organised collection of information about TB patients in France. This study aims to create one. By looking at all the health details of people diagnosed with TB, the researchers hope to find common factors or reasons why treatments might not be working as well as they should.
The main goal is to use this new understanding to improve how TB is treated and controlled in the future. By knowing more about the challenges patients face, healthcare professionals can develop better strategies, adjust treatments, and provide more effective support. Ultimately, the aim is to help more people successfully recover from TB and work towards significantly reducing the number of cases and deaths from this disease.
Key takeaways
- Tuberculosis (TB) is a serious global health concern.
- This study aims to understand why some TB treatments are not fully successful.
- It involves collecting routine health information from TB patients.
- The goal is to improve TB treatment and control for everyone.
- No new medication or procedures are part of this study.
- Patients' routine medical care will not be affected.
Who may be eligible?
To join this study, you would need to be 18 years old or older, up to 80 years old. You could be male or female. You must have been recently diagnosed with tuberculosis (TB) and be a new patient receiving treatment, either as an inpatient in hospital or an outpatient.
The TB diagnosis must be confirmed by tests, such as examining samples in the lab or through special scans. Even if the diagnosis isn't fully confirmed yet, you might still be able to join if your doctors strongly suspect you have TB and have decided to start you on treatment.
You would not be able to join if you don't want to take part, if you've already been taking anti-TB medication for more than 7 days, or if you're already involved in another research study.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you between 18 and 80 years old?
- Have you been newly diagnosed with tuberculosis (TB)?
- Are you starting treatment for TB (or have started less than 7 days ago)?
- Are you not currently involved in another research study?
- Are you happy for your health information to be used for research?
What does participation involve?
If you decide to take part in this study, you won't be given any new or experimental medications. Instead, the study involves collecting your health information related to your tuberculosis (TB) diagnosis and treatment. This is often called "data collection."
Researchers will gather details about your TB, your treatment plan, and how you respond to it over time. This will typically involve reviewing your medical records as part of your routine care. You will be followed for one year after you start your TB treatment. The study itself will run for at least five years in total, tracking many patients, but your individual participation will involve this 1-year follow-up period.
Potential risks and benefits
Locations (2)
- Hopital AvicenneVerified postcodeBobigny, France· Recruiting
- Hôpital AvicenneVerified postcodeBobigny, France· Not yet recruiting
Common questions
What is tuberculosis (TB)?
Tuberculosis (TB) is an infection, usually in the lungs, caused by a type of germ. It can make you feel unwell, cause a cough, and lead to serious health problems if not treated.
Will I be given new medicine in this study?
No, you will not receive any new or experimental medicines. This study is about collecting information from patients who are receiving standard care for their TB.
What kind of information will be collected about me?
Researchers will gather details from your medical records about your TB diagnosis, your treatment, and how you are responding to it as part of your usual care.
How long would I be involved in the study?
If you join, researchers will follow your health information for about one year after you start your TB treatment.
Why is this study important?
By understanding why some TB treatments don't work as well as expected, this study aims to improve care for future patients and help control TB on a larger scale.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.